"Hormone Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
| Descriptor ID |
D006727
|
| MeSH Number(s) |
D06.347 D27.505.696.399.450
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hormone Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Hormone Antagonists".
This graph shows the total number of publications written about "Hormone Antagonists" by people in this website by year, and whether "Hormone Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2009 | 0 | 2 | 2 |
| 2011 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hormone Antagonists" by people in Profiles.
-
Uterine fibroids in menopause and perimenopause. Menopause. 2020 02; 27(2):238-242.
-
Neurotrimin: a novel neural cell adhesion molecule correlating with uterine fibroid phenotype. Fertil Steril. 2020 01; 113(1):83-84.
-
Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 03; 131(3):431-439.
-
A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders. Fertil Steril. 2014 May; 101(5):1308-14.
-
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6163-72.
-
Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury. Microvasc Res. 2012 Mar; 83(2):194-9.
-
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2499-507.
-
Lipid effects of endocrine medications. Curr Atheroscler Rep. 2011 Feb; 13(1):88-94.
-
GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology. Expert Opin Drug Metab Toxicol. 2009 Oct; 5(10):1323-36.
-
Stress-induced changes in nucleus accumbens glutamate synaptic plasticity. J Neurophysiol. 2009 Jun; 101(6):3192-8.